Answers are grounded in this paper and cite their sources.
In vitro assessment of SA-31 shows neuroprotection against neurotoxicity, indicating potential benefits in addiction and neurodegenerative diseases.
These findings suggest that SA-31 confers neuroprotection by enhancing MS activity, upregulating antioxidant defenses, and improving mitochondrial function. Further studies in rodent models of addiction are planned to evaluate its therapeutic potential for psychostimulant use disorders and related neurodegenerative conditions.
No takes yet. Share an insight, caveat, or question.
Amankwa et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: